GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17%

GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now. On February 4, GSK plc (NYSE:GSK) announced fourth-quarter earnings that outperformed analyst estimates in several important metrics. Earnings per share for the quarter came in at $0.6989, 9.58% more than the forecast of $0.6378. Revenue also surpassed forecasts, coming in at $11.81 billion versus $11.36 billion, for a 3.96% upside surprise. Pixabay/Public Domain Specialty Medicines was a fairly promising area, with 17% grow ...